| Dr Joshua Avram Boyce, MD | |
|
850 Boylston St Suite 540, Bwh Rheumatology Immunology And Allergy, Chestnut Hill, MA 02467 | |
| (617) 278-0300 | |
| Not Available |
| Full Name | Dr Joshua Avram Boyce |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 39 Years |
| Location | 850 Boylston St Suite 540, Chestnut Hill, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285608919 | NPI | - | NPPES |
| 3038432 | Medicaid | MA | |
| 724769 | Other | MA | TUFTS HEALTH PLAN |
| J07764 | Other | MA | BCBS MA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Brigham And Women's Physicians Organization Inc | 3870405988 | 2510 |
News Archive
The first U.S. clinical trial using genetic screening to identify lung tumors likely to respond to targeted therapies supports the use of those drugs as first-line treatment rather than after standard chemotherapy has failed.
New cancer drugs taken in pill form have become dramatically more expensive in their first year on the market compared with drugs launched 15 years ago, a University of North Carolina at Chapel Hill study has found. The findings call into question the sustainability of a system that sets high prices at market entry in addition to rapidly increasing those prices over time.
A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.
At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
› Verified 6 days ago
| Entity Name | Brigham And Women's Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033535497 PECOS PAC ID: 3870405988 Enrollment ID: O20150107001260 |
News Archive
The first U.S. clinical trial using genetic screening to identify lung tumors likely to respond to targeted therapies supports the use of those drugs as first-line treatment rather than after standard chemotherapy has failed.
New cancer drugs taken in pill form have become dramatically more expensive in their first year on the market compared with drugs launched 15 years ago, a University of North Carolina at Chapel Hill study has found. The findings call into question the sustainability of a system that sets high prices at market entry in addition to rapidly increasing those prices over time.
A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.
At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joshua Avram Boyce, MD 111 Cypress St, Brigham And Womens Physicians Organization, Brookline, MA 02445 Ph: (857) 307-0896 | Dr Joshua Avram Boyce, MD 850 Boylston St Suite 540, Bwh Rheumatology Immunology And Allergy, Chestnut Hill, MA 02467 Ph: (617) 278-0300 |
News Archive
The first U.S. clinical trial using genetic screening to identify lung tumors likely to respond to targeted therapies supports the use of those drugs as first-line treatment rather than after standard chemotherapy has failed.
New cancer drugs taken in pill form have become dramatically more expensive in their first year on the market compared with drugs launched 15 years ago, a University of North Carolina at Chapel Hill study has found. The findings call into question the sustainability of a system that sets high prices at market entry in addition to rapidly increasing those prices over time.
A new study published today demonstrates that a technology developed at the University of Central Florida could serve as a more reliable clinically-based model of amyotrophic lateral sclerosis (ALS) and a better screening tool for novel therapies than currently use preclinical models.
At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).
› Verified 6 days ago
Daniel G Steinberg, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 25 Boylston Street, Suite #215, Allergy & Asthma Center Of Ma, Chestnut Hill, MA 02467 Phone: 617-232-1690 | |
Laura Beth Fanning, Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 850 Boylston St, Suite 540, Chestnut Hill, MA 02467 Phone: 617-732-9850 | |
Dr. David In-chull Hong, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 850 Boylston St, Suite 540, Chestnut Hill, MA 02467 Phone: 617-732-9850 | |
Dr. Anna M Feldweg, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 850 Boylston St, Ste 540, Chestnut Hill, MA 02467 Phone: 617-278-0300 Fax: 617-731-2748 | |
Jonathan Arm, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 850 Boylston St, Ste 540, Chestnut Hill, MA 02467 Phone: 617-732-5500 | |
Dr. Jessica Rabe Savage, MD, MHS Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 850 Boylston St, Chestnut Hill, MA 02467 Phone: 617-732-9850 |